Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MERWIS

Financiado

Cerrado

Melanoma Early Warning System

However, there are several tools and solutions for aiding the melanoma detection (variable dermatoscopes, full-body mapping tools and Applications), they were not able to achieve breakthrough in the early diagnosis phase. It comes... ver más

31/12/2019

NEXCON

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

NEXCON TECHNOLOGIAI TANACSADO ES SZOLGALTATO... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-12-31

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

NEXCON

50.00K€ | Lider

ARCELORMITTAL ESPANA

508.28K€ | Participante

Proyectos interesantes

iToBoS

Medical Technol...

Artificial Inte...

12M€ Cerrado

DEVISKAN. LA INTELIGENCIA ARTIFICIAL ORIENTAD...

Medical Technol...

Artificial Inte...

382K€ Cerrado

SWAN

Medical Technol...

Software

4M€ Cerrado

MOLEGAZER

Medical Technol...

Artificial Inte...

150K€ Cerrado

EIN2020-112457

Medical Technol...

Data Science

15K€ Cerrado

Miiskin

Medical Technol...

Data Science

71K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 5 meses Fecha Inicio: 2019-07-31
Fecha Fin: 2019-12-31

Líder del proyecto

NEXCON TECHNOLOGIAI TANACSADO ES SZOLGALTATO... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto However, there are several tools and solutions for aiding the melanoma detection (variable dermatoscopes, full-body mapping tools and Applications), they were not able to achieve breakthrough in the early diagnosis phase. It comes from the wrong methodologies. There are two types of available tools: 1) diagnostic tools, whit the aim of diagnosing skin-cancer without human intervention, and 2) medical equipment, which help the work of dermatologist during the examination in a doctor’s office. The problem with first methodology (artificial based skin-cancer diagnosis) is that these do not work reliable or do not work at all. The main problem of the second methodology is the very rare examination frequency. An average health conscious European adult visits skin-cancer screening in every 3-7 years. In contrast with these, MERWIS offers a solution that focuses on increasing the examination frequency, where the system does not need to establish a full diagnosis. MERWIS only looks for evolution (change) of every single monitored mole, but with high or very high frequency. The validated and demonstrated MERWIS prototype is based on the fact that most clinical signs of melanoma are all visible. Through using the combination of a special body-mapping cabin, a mobile application based self dermoscopy, and a computer assisted qualitative data analysis software we can detect all the visible changes of melanoma ABCDE. Furthermore our system uses a custom made distributed ledger technology-based network cloud solution. Based on this framework it is possible to build the MERWIS decentralized database on a maximum security level and ensure scalability. The aim of this Phase 1 project is to carry out an extended feasibility study consisting of market assessment, business model validation, risk and IP strategy assessment, up-date and advancement of the business plan, and international pilot location selection to support the global commercialisation of our technology.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores